About
NuvoBio develops peptide therapeutics using a proprietary AI-driven platform, DarwinAI, which integrates computational modeling and experimental validation to design peptides with enhanced specificity and reduced off-target effects for therapeutic applications.
Explore NuvoBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.